* Eton Pharmaceuticals Inc ETON.OQ ETON.O is expected
to show
a rise in quarterly revenue when it reports results on March
16.
* The Deer Park Illinois-based company is expected to
report a
49.7% increase in revenue to $9.119 million from $6.09 million a
year ago, according to the estimate from one analyst, based on
Refinitiv data.
* Refinitiv's mean analyst estimate for Eton
Pharmaceuticals Inc
is for earnings of 1 cent per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Eton
Pharmaceuticals Inc is $10, above its last closing price
of $3.86.
This summary was machine generated March 14 at 20:12 GMT. All
figures in US dollars unless otherwise stated